Over 65 million people have epilepsy and around one third of these people have uncontrolled seizures with a 30% error rate in diagnostics. Seer is reimagining how and where people undergo long-term brain, heart, and respiratory monitoring for faster paths to diagnoses and better patient outcomes. Seer’s solutions include an at-home epilepsy monitoring system and wearable medical devices, mobile apps for tracking and forecasting seizures, and cloud technology that translates big data into useful medical insights.
Since its launch in 2017, Seer’s at-home epilepsy diagnosis service has helped over 10,000 Australians gain access to gold-standard medical care. Seer has raised $44 million to date from investors including Cochlear, EWM Group, SG Hiscock and Giant Leap.